Sterneck Capital Management, LLC Synthetic Biologics, Inc. Transaction History

Sterneck Capital Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 03, 2022	SELL	$2.3 - $4.3 $57,499 - $107,500	-25,000 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$4.6 - $7.2 $114,999 - $180,000	25,000 New	25,000 $13,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Sterneck Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sterneck Capital Management, LLC with notifications on news.